Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-25-057683

Chief Executive Officer acquired 55,117 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brumm Joshua T · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-15 Grant or award : show line 1 in the form +45,117 313,517 D
2025-12-15 Grant or award : show line 2 in the form +10,000 323,517 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-15 Grant or award : show line 3 in the form Stock Option (Right to Buy) +180,467 180,467 D
Loading xslF345X05/wk-form4_1766007988.xml…